Frankfurt - Delayed Quote EUR

Capricor Therapeutics, Inc. (4LN2.F)

Compare
14.40
+0.96
+(7.14%)
As of 3:29:02 PM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
23,228.05
25,178.07
2,551.47
244.90
310.25
Operating Expense
59,376.34
49,255.93
32,248.85
21,183.34
14,000.22
Operating Income
-36,148.29
-24,077.86
-29,697.38
-20,938.44
-13,689.97
Other Income Expense
2,035.62
1,790.32
677.85
915.92
32.94
Pretax Income
-34,112.67
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Net Income Common Stockholders
-34,112.67
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Diluted NI Available to Com Stockholders
-34,112.67
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Basic EPS
-1.02
-0.83
-1.18
-0.87
-0.88
Diluted EPS
-1.02
-0.83
-1.18
-0.87
-0.88
Basic Average Shares
31,751.09
26,778.36
24,552.69
23,089.32
15,571.06
Diluted Average Shares
31,751.09
26,778.36
24,552.69
23,089.32
15,571.06
Total Operating Income as Reported
-36,148.29
-24,077.86
-29,697.38
-20,938.44
-13,689.97
Total Expenses
59,376.34
49,255.93
32,248.85
21,183.34
14,000.22
Net Income from Continuing & Discontinued Operation
-34,112.67
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Normalized Income
-36,080.64
-24,010.20
-29,506.80
-20,390.24
-13,689.97
EBIT
-36,148.29
-24,077.86
-29,697.38
-20,938.44
-13,689.97
EBITDA
-34,791.18
-23,008.98
-29,164.25
-20,692.75
-13,546.08
Reconciled Depreciation
1,357.12
1,068.88
533.13
245.70
143.89
Net Income from Continuing Operation Net Minority Interest
-34,112.67
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Total Unusual Items Excluding Goodwill
1,967.96
1,722.66
487.27
367.72
32.94
Total Unusual Items
1,967.96
1,722.66
487.27
367.72
32.94
Normalized EBITDA
-36,759.14
-24,731.64
-29,651.52
-21,060.46
-13,579.02
12/31/2020 - 12/8/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2LB.BE Iovance Biotherapeutics Inc
5.99
+0.67%
 
2LB.F Iovance Biotherapeutics, Inc.
5.99
+0.77%
 
MOOD.CN Doseology Sciences Inc.
0.1200
0.00%
 
IFRX InflaRx N.V.
2.4400
+2.95%
 
SLRX Salarius Pharmaceuticals, Inc.
2.1700
+0.93%
 
AUTL Autolus Therapeutics plc
2.2350
+1.59%
 
CABA Cabaletta Bio, Inc.
2.4609
+5.17%
 
CTXR Citius Pharmaceuticals, Inc.
2.7299
-3.54%
 
CRDF Cardiff Oncology, Inc.
4.0312
+1.54%
 
HOTH Hoth Therapeutics, Inc.
1.2900
+0.79%